Drug distributor Cardinal Health to lose OptumRx contracts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 dips, Nasdaq higher on modest rise in inflation
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 flat as higher bond yields counter tech optimism
Baird Defends Cardinal Health (CAH): 'Market fears played out, buyers on weakness'
April 23, 2024 6:21 AM EDTBaird analyst Eric Coldwell reiterated an Outperform rating and $134.00 price target on Cardinal Health (NYSE: CAH).
The analyst comments "Market fears played out, buyers on weakness. We have long posited that CAH could well absorb loss of OptumRx given strong underlying market fundamentals,... More
Cardinal Health (CAH) shares down after losing OptumRx contracts
April 22, 2024 4:00 PM EDTShares of Cardinal Health (NYSE: CAH) fell 5% Monday after the company said that its contracts with UnitedHealth Group's (NYSE: UNH) OptumRx will not be renewed after they expire at the end of June.
Analysts from at least two firms believe that McKesson, a rival company, is likely... More
